According to her, since 2004, chronic leukemia has been registered in Kyrgyzstan, and currently, more than 500 people need treatment. Of these, 90% are adults, and 10% are children. The deputy clarified that the drug "Gleevec" is supplied to the country thanks to a European fund, and the National Center for Oncology and Hematology acts as the official partner of the humanitarian initiative.
Egenberdieva noted that patients are forced to take this medication for their entire lives.
The deputy also emphasized that residents of the southern regions of the country have to travel to Bishkek every month to obtain the medication, which incurs travel and accommodation costs amounting to 15,000-20,000 soms. At the same time, they often face long queues and may wait for the medication in the capital for up to a week.
She proposed organizing the distribution of "Gleevec" in regions such as Osh, Jalal-Abad, and Batken. As distribution points, she mentioned the Osh Regional Oncology Hospital and the Osh Regional Unified Clinical Hospital, which has a hematology department, allowing patients to reduce their trips to Bishkek.
"This is not just a matter of numbers and documents, but a matter concerning human life," she noted, calling for a protocol assignment to the Ministry of Health to address this issue.
Additionally, the deputy touched upon the topic of medical care in the village of Tuzbel in the Jalpak-Tash Ayil Aimak of the Uzgen district. This village has a population of over 7,800 people; however, the local hospital is in a state of emergency. The facility lacks doctors, with only nurses working there.
According to her, at night, emergency patients are left without necessary medical supervision, and they have to travel to the village of Kurshab, which takes about 45 minutes. Egenberdieva emphasized that in winter, this situation worsens due to difficult weather conditions.
